T. F. Shepard

The Prognostic Significance of Plasma Interleukin-6 Levels in Patients with Metastatic Hormone-Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 9480

P. Kantoff, E. Small, N. Vogelzang, 2005, Clinical Cancer Research.

Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.

P. Kantoff, E. Small, D. Hayes, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective study.

P. Febbo, P. Kantoff, M. Stampfer, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Amplified in breast cancer-1 glutamine repeat and prostate cancer risk

P. Kantoff, M. Stampfer, E. Giovannucci, 2000 .

PTEN polymorphism (IVS4) is not associated with risk of prostate cancer.

P. Kantoff, M. Stampfer, E. Giovannucci, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.